Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
EditorialEditorial

Guidelines on Similar Biologics: Regulatory Requirements for Marketing Authorization in India

Anurag Rathore
PDA Journal of Pharmaceutical Science and Technology September 2012, 66 (5) 393; DOI: https://doi.org/10.5731/pdajpst.2012.00886
Anurag Rathore
Department of Chemical Engineering Indian Institute of Technology, Delhi Hauz Khas, New Delhi, 110016, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: journal@pda.org
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 66 no. 5 393
DOI 
https://doi.org/10.5731/pdajpst.2012.00886
PubMed 
23035022

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online October 3, 2012.

Copyright & Usage 
© PDA, Inc. 2012

Author Information

Cited By...

  • 11 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin’s Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration
    Ramandeep Singh, Rohan Chauhan, Ashish Saxena, Anup Shah, Laxshmi Mondal, Dhananjay Bakhle, Chirag Shah, Arpit Shah, Shashank Deoghare, Neelakant Krishnan, Neelima Godse
    Indian Journal of Ophthalmology 2022 70 8
  • Similar biologics in India
    Ramesh Jois, Sukumar Mukherjee, S. Rajeswari, P.D. Rath, Vishal Goyal, Disha Gupta
    Indian Journal of Medical Research 2020 152 5
  • Biosimilars: An Approach to some Current Worldwide Regulation Frameworks
    Efraín Esteban, Rosa-Helena Bustos, Julio-César García, Edwin Jáuregui
    Current Clinical Pharmacology 2019 14 1
  • Comparison of glycoprofiles of rituximab versions licensed for sale in India and an analytical approach for quality assessment
    Tejinder Kaur, Bhupendra Nath Shukla, Vinay Kumar Yadav, Mahesh J. Kulkarni, Alka Rao
    Journal of Proteomics 2021 244
  • Multiple-parallel-protease digestion coupled with high-resolution mass spectrometry: An approach towards comprehensive peptide mapping of therapeutic mAbs
    Gauri Pradhan, J.M. Sneha, Babasaheb P. Sonwane, B. Santhakumari, Alka Rao, Mahesh J. Kulkarni
    Journal of Proteomics 2021 232
  • Biosimilars: A Critical Review of Development, Regulatory Landscape, and Clinical Implications
    Ankit Monga, Gagan, Pragya Jamwal, Sumit Sharma, Amanpreet Kaur
    AAPS PharmSciTech 2025 26 1
  • Medico-legal aspects in ophthalmology in India
    Murali Ariga, Mohana Sinnasamy, NirmalThomas Fredrick, VG Madanagopalan, V Subashini, Tarun Murali
    TNOA Journal of Ophthalmic Science and Research 2023 61 3
  • A prospective, open-label, randomised, parallel design study of 4 generic formulations of intramuscular L-asparaginase in childhood precursor B-cell acute lymphoblastic leukaemia (ALL)
    Suja Johnson, Chetan Dhamne, Hari Sankaran, Khushboo A. Gandhi, Pallavi Rane, Nirmaly Roy Moulik, Shraddha Mahesh Jadhav, Murari Gurjar, Gaurav Narula, Shripad Banavali, Vikram Gota
    Cancer Chemotherapy and Pharmacology 2022 90 6
  • Biologics and Biosimilars: Navigating Production, Approval, Applications and Challenges
    Nandini Jaynarayan Tiwari, Kantilal B. Narkhede, Anuradha Prajapati, Sachin B. Narkhede, Shailesh Luhar
    Asian Journal of Research in Pharmaceutical Sciences 2025
  • Biosimilars for Cancer Treatment
    Satish Shilpi, Ekta Gurnany, Pawan K. Gupta, Kangan Sharma, Khyati Saini, Pranali Chimaniya, Shvetank Bhatt
    2024
  • Efficacy and Safety of Biosimilar Ranibizumab (OPTIMAB®) versus Innovator Ranibizumab in Patients with Neovascular (Wet) Age-Related Macular Degeneration: A Double-Blind, Randomized, Multicenter, Phase III Study
    Parth Rana, Himanshu Deshmukh, Urmil Shah, Vinod Kumar, Sanghamitra Kanungo, Deepika Singhal, Santosh Kumar Mahapatra, Ira Vakharia, Mukesh Jaiswal, Ajitkumar Gondane, Pooja Vaidya, Vinayaka Shahavi, Harish Shandilya, Dattatray Pawar, Akhilesh Sharma
    Clinical Ophthalmology 2024 Volume 18
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 66 (5)
PDA Journal of Pharmaceutical Science and Technology
Vol. 66, Issue 5
September/October 2012
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Guidelines on Similar Biologics: Regulatory Requirements for Marketing Authorization in India
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Guidelines on Similar Biologics: Regulatory Requirements for Marketing Authorization in India
Anurag Rathore
PDA Journal of Pharmaceutical Science and Technology Sep 2012, 66 (5) 393; DOI: 10.5731/pdajpst.2012.00886

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Guidelines on Similar Biologics: Regulatory Requirements for Marketing Authorization in India
Anurag Rathore
PDA Journal of Pharmaceutical Science and Technology Sep 2012, 66 (5) 393; DOI: 10.5731/pdajpst.2012.00886
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • PDA Journal Editorial Board-An Update
  • Quality Assurance
  • 2025 January/February Editorial
Show more Editorial

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire